Review
. 1989 Nov 15;24(11):89-92, 97-100, 103-6.
doi: 10.1080/21548331.1989.11703812.
Anabolic steroid therapies for growth disorders
Affiliations
- PMID: 2509505
- DOI: 10.1080/21548331.1989.11703812
Item in Clipboard
Review
Anabolic steroid therapies for growth disorders
Hosp Pract (Off Ed).
.
Abstract
Until recently, human growth hormone was the only endocrine therapy available for promotion of growth and development. Dramatic progress in understanding the secretory and regulatory pathways pertinent to the anabolic steroids has led to multiple pharmacologic approaches. Growth hormone dynamics and its impact on therapy are discussed.
Similar articles
-
Current research on recombinant human growth hormone and the related growth factors, IGF-1 and GRF.Acta Paediatr Scand Suppl. 1986;325:85-9. doi: 10.1111/j.1651-2227.1986.tb10371.x. Acta Paediatr Scand Suppl. 1986. PMID: 3109208
-
[Therapeutic indications in growth retardation].Presse Med. 1991 Feb 2;20(4):149-51. Presse Med. 1991. PMID: 1825869 French. No abstract available.
-
[Taller with growth hormones?].Tijdschr Kindergeneeskd. 1988 May;56 Suppl 1:1-3. Tijdschr Kindergeneeskd. 1988. PMID: 3137693 Dutch. No abstract available.
-
The role of insulin, growth hormone and IGF-I as anabolic agents in the critically ill.Intensive Care Med. 1993;19 Suppl 2:S54-7. doi: 10.1007/BF01708801. Intensive Care Med. 1993. PMID: 7508957 Review. No abstract available.
-
Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth.Endocr Rev. 1987 Nov;8(4):426-38. doi: 10.1210/edrv-8-4-426. Endocr Rev. 1987. PMID: 3319530 Review. No abstract available.
Cited by
-
Effect of transcutaneous electrical nerve stimulation, cold, and a combination treatment on pain, decreased range of motion, and strength loss associated with delayed onset muscle soreness.J Athl Train. 1992;27(3):200-6. J Athl Train. 1992. PMID: 16558162 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical